Navigation Links
Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
Date:3/12/2009

NG-PLOUGH DISCLOSURE NOTICE: The information in this press release contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to potential of SCH 530348 (TRA) and further actions under the clinical trials. Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Item 1A. "Risk Factors" in the 2008 10-K, filed February 27, 2009.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
2. Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation
3. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
4. Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
5. Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting
6. Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors
7. Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
8. Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207
9. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
10. Millennium Presents New Data on Investigational Drugs for Novel Cancer Targets at EORTC-NCI-AACR Symposium
11. Berlin Hearts EXCOR(R) Pediatric Receives Unconditional Investigational Device Exemption (IDE) Approval
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... DUBLIN , Apr. 16, 2015 Research ... announced the addition of the "The Corporate ... 2014 - Global Edition " report to ... Pharmafrom a Patient Perspective, is now in its ... (2014 results; published early 2015). For each annual ...
(Date:4/17/2015)... , April 17, 2015 Bionomics Limited (ASX:BNO, ... development of innovative therapeutics for the treatment of cancer ... the presentation of data from three of its most ... Cancer Research (AACR) 106 th Annual Meeting being ... PA USA. The presentation ...
(Date:4/16/2015)... 2015 Mindray Medical International Limited (NYSE: ... of medical devices worldwide, announced today that it ... Annual Report on Form 20-F that included audited ... An electronic version of Mindray,s Annual Report on ... website at  http://ir.mindray.com  or  http://www.sec.gov . ...
Breaking Medicine Technology:The Corporate Reputation of Pharma - The Global Patient Perspective in 2014 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2
... (NASDAQ: SPEX ) -- an innovator in ... and providers of technical and regulatory consulting services to ... that Dr. Claire Kruger, Chief Executive Officer, and Dr. ... at the Rodman & Renshaw 13th Annual Healthcare Conference ...
... a article published in the August issue of the Journal ... Distinguished Professor of Health Law & Executive Director, Institute of ... and Mr. Tim Mackey, Senior Research Associate at IHLS and ... California, San Diego – San Diego State University, assess the ...
Cached Medicine Technology:Spherix Incorporated to Present at the Rodman & Renshaw 13th Annual Healthcare Conference 2JMIR Article by IHLS Authors Discusses Global Public Health Implications of Social Media Direct-to-Consumer Advertising by Illicit Online Pharmacies and Private Entities 2
(Date:4/19/2015)... April 19, 2015 McCann Investigations, a ... announce the publication of white paper Married, but ... As online media provides a unique environment of ... market specifically targeting adulterous spouses has emerged. Social ... becomes as easy as shopping online. Dating sites ...
(Date:4/19/2015)... 19, 2015 HealthPostures, LLC , a ... it will exhibit it’s pioneering ergonomics products at the ... Iowa-Illinois Safety Council Professional Development Conference and Expo . ... EZ are used in volume by call centers, educational ... Built to clamp to a desk, the TaskMate Go ...
(Date:4/18/2015)... April 18, 2015 Compare-autoinsurance.org has released ... reliable auto insurance policy . , Clients ... car insurance quotes online is safe and reliable. An ... The quotes are displayed on a single web page, ... , It is now possible to compare online ...
(Date:4/18/2015)... Carinsurancehints.com has released a new blog post explaining how ... protection against fire damage. , Clients can now find ... vehicle is set intentionally on fire. This type of damages ... other things. , It is possible to compare the ... http://www.carinsurancehints.com/ , in just a few minutes. Clients should ...
(Date:4/18/2015)... Review of Ophthalmology magazine and Abbot ... Success’ program for cataract surgeons attending the American Society ... where eye surgeon Jeffrey L. Martin, MD will serve ... Martin is the Managing Partner of North Shore Eye ... Martin to lead this year’s discussion on the latest ...
Breaking Medicine News(10 mins):Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2Health News:HealthPostures' TaskMate Products to be Exhibited at the Wisconsin and Iowa-Illinois Safety Conferences 2Health News:A Guide For Avoiding Online Auto Insurance Scams! 2Health News:Online Auto Insurance Quotes For Plans That Cover Fire Damages! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2
... N.Y. -- Today,s major announcement at the American Society ... significantly reduces the risk of breast cancer in high-risk, ... double-blind phase III clinical trial in which University at ... played a critical role. The findings will be ...
... Steven Reinberg HealthDay Reporter , FRIDAY, June ... can see their chances of the cancer,s return drop ... added to regular hormone therapy for three years after ... for breast cancer are prone to develop osteoporosis, so ...
... Ellin Holohan HealthDay Reporter , FRIDAY, June ... help ease the hot flashes, night sweats and insomnia ... of Massachusetts research showed that mindfulness training, based on ... hot flashes and improved physical, psychosocial and sexual functioning. ...
... -- ASCO Abstract #10504. Contrary to what many oncologists had ... reduce the effectiveness of the breast cancer drug Herceptin, according ... North Central Cancer Research Group (NCCTG) investigators. The study, ... NCCTG N9831 clinical trial, found that patients with HER2-positive breast ...
... each targeting a prime survival strategy of tumors, can ... either drug alone for advanced, inoperable melanomas, according to ... Institute investigators. The findings (abstract 8511), will be ... of the American Society of Clinical Oncology on Saturday, ...
... Customizing targeted therapies to each tumor,s molecular characteristics, ... be more effective for some types of cancer, according ... Anderson Cancer Center. MD Anderson,s Phase I findings ... the 47th Annual Meeting of the American Society of ...
Cached Medicine News:Health News:UB played major role in study on drug that reduces breast cancer in high-risk women 2Health News:UB played major role in study on drug that reduces breast cancer in high-risk women 3Health News:Bone Drug Reduces Odds for Breast Cancer's Return: Study 2Health News:Bone Drug Reduces Odds for Breast Cancer's Return: Study 3Health News:Meditation May Help Women Cope With Hot Flashes 2Health News:Meditation May Help Women Cope With Hot Flashes 3Health News:Mayo Clinic, NCCTG find no tie between PTEN and response to breast cancer drug 2Health News:Combination antibody therapy shows promise in metastatic melanoma 2Health News:Matching targeted therapies to tumor's specific gene mutations key to personalized cancer treatment 2Health News:Matching targeted therapies to tumor's specific gene mutations key to personalized cancer treatment 3Health News:Matching targeted therapies to tumor's specific gene mutations key to personalized cancer treatment 4
... System is a rapid, real-time thermal cycler ... samples. By automating much of the testing ... programmable, it is the fastest, easiest to ... the market. The SmartCycler delivers highly accurate ...
... Real Time Thermal Block and its ... such as quantification of gene expression, ... and validation of microarray results. Exicycler ... between two molecules, such as protein-protein ...
... converts any DNA Engine thermal cycler into a ... any of our user-changeable sample blocks. The small ... to keep pace with the evolving needs of ... Engine base units, new or existing. The Chromo4 ...
Mx3000P instrument, desktop computer, Mx3000P software package, user's manual, one Brilliant QPCR Reagent of your choice, and custom filter wheel with 4 filters chosen from: FAM/SYBR Green I, TET, HE...
Medicine Products: